C71T
CANCELLED SECTION 71
06/03/2026
Voltar para busca
Dado oficial do USPTO
DUOBODY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
56
Atualização mais recente
31/03/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42, 45
Data de depósito
06/06/2013
Data de registro
12/08/2014
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/03/2026
Última transação
31/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
16
Localização do titular
DK
Examinador
BULLOFF, TOBY ELLEN
Unidade examinadora
N10
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Genmab A/S
Representantes
Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalbiochemicalbiological and biotechnological preparationsespecially antibodiesbi and multi specific antibodies as well as fragmentsincluding monovalent antibodiesderivatives or conjugates of any of theseall for vitro and in vivo scientific and industrial research and development with regard to diseases
Classe 5
Pharmaceutical and veterinary preparationspharmaceutical preparations based on antibodiesbi and multispecific antibodies as well as fragmentsincluding monovalent antibodiesderivatives or conjugates of any of these for use with regard to treatment of cancerinfectious diseasesimmune and autoimmune diseasesinflammatory diseasesneurodegenerative diseases and cardiovascular diseases
Classe 42
Medicalscientific and biological researchespecially research into antibodies and bi and multispecific antibodies or fragmentsincluding monovalent antibodiesderivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi and multispecific antibodies or fragmentsincluding monovalent antibodiesderivatives or conjugates of any of these; chemical analysis; computer programmingprogramming of computers for the collection and processing of medical data in medical scientific researchdevelopment and therapyincluding scientific researchdevelopment and therapy with antibodiesbi and multispecific antibodies or fragmentsincluding monovalent antibodiesderivatives or conjugates of any of these
Classe 45
Legal services in the form of patent exploitation and licensing of intellectual property in the field of medicines
Publicações
Histórico de despachos e eventos da marca no USPTO.
56 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/03/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/06/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/06/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/06/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/06/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/06/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/06/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
15/09/2023
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
12/08/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
07/04/2023
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
25/12/2021
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
14/11/2021
INPC
INVALIDATION PROCESSED
14/11/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
24/10/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
24/02/2021
71AG
REGISTERED-SEC.71 ACCEPTED
24/02/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/02/2021
ES71
TEAS SECTION 71 RECEIVED
03/02/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
26/10/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/09/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
20/04/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/02/2017
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/02/2017
PRA7
REGISTERED - SEC. 7 REQUEST ABANDONED
27/07/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/02/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/01/2015
FIMP
FINAL DISPOSITION PROCESSED
27/01/2015
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/11/2014
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
22/09/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
14/09/2014
ES7R
TEAS SECTION 7 REQUEST RECEIVED
04/09/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
12/08/2014
PUBO
PUBLISHED FOR OPPOSITION
27/05/2014
GPNX
NOTIFICATION PROCESSED BY IB
23/05/2014
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/05/2014
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/05/2014
NPUB
NOTICE OF PUBLICATION
07/05/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
24/04/2014
ALIE
ASSIGNED TO LIE
24/04/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/04/2014
CNEA
EXAMINERS AMENDMENT MAILED
02/04/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
02/04/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/04/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/03/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/03/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/03/2014
RFNT
REFUSAL PROCESSED BY IB
16/10/2013
MAFR
APPLICATION FILING RECEIPT MAILED
24/09/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/09/2013
RFRR
REFUSAL PROCESSED BY MPU
23/09/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/09/2013
CNRT
NON-FINAL ACTION WRITTEN
20/09/2013
DOCK
ASSIGNED TO EXAMINER
19/09/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/09/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/09/2013
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DUOBODY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.